2023 annual financial data
Mineralys Therapeutics 2023 Operating margin
Mineralys Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -84,657,000 USD and net income was -71,898,000 USD.
Operating cash flow was -81,173,000 USD.
Get free Mineralys Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -84,657,000 USD
- Net income
- -71,898,000 USD
- Operating cash flow
- -81,173,000 USD